Europe — EMA
Nicorandil Zentiva
GNH USA supplies Nicorandil Zentiva (Nicorandil), a vasodilator for angina pectoris. Request a quote for global supply to hospitals, pharmacies and clinics
Request sourcing
What is Nicorandil?
Nicorandil, the active ingredient in Nicorandil Zentiva, is a potassium channel activator/vasodilator presented as an oral dosage form for oral use. It is used to treat angina pectoris in adult patients.
GNH USA supplies Nicorandil Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Nicorandil used for?
Nicorandil is indicated for conditions involving myocardial ischemia and related chest pain.
- Angina pectoris: reduces frequency of chest pain episodes by improving coronary blood flow.
What are the side effects of Nicorandil?
Nicorandil may cause a range of adverse reactions, which are categorized by frequency.
Common Side Effects: - Headache: mild to moderate headache reported. - Flushing: transient facial flushing. - Dizziness: occasional sensation of light‑headedness. - Nausea: mild gastrointestinal upset.
Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Angina worsening: paradoxical increase in chest pain. - Allergic reactions: rash, urticaria, or anaphylaxis. - Gastro‑intestinal ulceration: rare but serious ulcer formation.
What precautions apply to Nicorandil?
When prescribing Nicorandil, clinicians should consider the following precautions.
- Cardiovascular disease: monitor blood pressure and heart rate closely. - Renal impairment: use with caution and adjust dosing as needed. - Hepatic dysfunction: assess liver function before initiation. - Concomitant vasodilators: increased risk of hypotension. - Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. - Store at room temperature below 25°C: keep in original container, protect from moisture.
What does Nicorandil interact with?
Nicorandil can interact with other medicines, affecting its efficacy or safety.
Major Interactions (Avoid): - Nitrates (e.g., nitroglycerin): additive vasodilation may cause severe hypotension. - Sildenafil or other PDE‑5 inhibitors: risk of profound blood pressure fall. - Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): may enhance hypotensive effect.
Moderate Interactions (Monitor Closely): - Diuretics: may increase risk of electrolyte imbalance. - Calcium channel blockers: additive effect on vascular tone. - Antiplatelet drugs: potential for increased bleeding risk.



